Cannabis Law Report

JANUARY 31, 2022

Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. At this time, Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Holiday Pay.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Holiday Pay.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

Canna Law Blog

APRIL 27, 2020

According to the FDA’s press release : The opioid crisis continues to be a serious problem in the United States, and we will continue to crack down on companies that attempt to benefit from selling products with unfounded treatment claims,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D.,

CBD 58

CBD Topical Oil Treatment 58

Cannabis Law Report

AUGUST 10, 2021

The acquisition combines proven high quality dried flower sales and industry-leading yields with immediate facility expansion, increased capacity, enhanced product development, key sales licences, existing provincial supply deals, and direct distribution to medical patients focused on Veterans. MONTRÉAL, Aug. providing approx.

Seed-To-Sale 105

Seed-To-Sale Cultivation Patients Cannabis 105

Veriheal

MARCH 23, 2022

Bronner’s expressed gratitude and excitement for its new partnership with healthcare organization Enthea to expand its employee medical benefits to include psychedelic therapies. Enthea is expected to expand its psychedelic treatment options to include other substances, such as psilocybin and MDMA , pending FDA approval.

Therapy 82

Therapy Treatment Supply Chain Pharmaceutical 82

Marijuana Packaging

NOVEMBER 23, 2018

Currently, New England Treatment Access (NETA) in Northampton and Cultivate Holdings in Leicester are the two spots that are selling, with the mayor of Northampton being one of the first customers. Massachusetts Recreational Sales Have Officially Begun. Massachusetts recreational cannabis sales are go. Is New Jersey Next to Legalize?

Legalization 40

Legalization Recreational Therapy Dispensary 40

Cannabis Law Report

JULY 30, 2019

The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” ” These patients then have access to purchasing the substance from a regulated state dispensary.

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. In contrast, it is unclear to what extent people most in need of psychedelic therapies will benefit.

Law 105

Law Research and Development Therapy DEA 105

CannaMD

MAY 14, 2020

CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements. Safety of production and packaging. Risks of over-consumption and accidental ingestion.

Edibles 105

Edibles Marijuana THC Vaping 105

The Cannigma

MAY 15, 2023

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

The Cannigma

FEBRUARY 16, 2022

I was like, it’d be cool, if whatever rush you get, that runner’s high, that endorphin, I said, if you could get that and package it, and you could just take that on a regular basis as an athlete, wouldn’t that be amazing? Well, I think what opened it up for me was, I always joked, we’re biohacking. CP: I’m great.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

OCTOBER 29, 2019

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. Each treatment lasted for 4 weeks with a 2-week washout period. Veterinary assessment showed decreased pain during CBD treatment ( p < 0.02).

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73